You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 17981 - 17990 of 19116 results
  1. PT7: Therapeutic Molecules

    Release Date: 12-18-2019Open Date: 12-18-2019 Due Dates: Multiple Close Date: 12-03-2020

    PT7 NSF SBIR Phase I (2020) National Science Foundation ...

    SBIRPhase INational Science Foundation
  2. PT7: Therapeutic Molecules

    Release Date: 12-18-2019Open Date: 12-18-2019 Due Dates: Multiple Close Date: 12-03-2020

    PT7 NSF STTR Phase I (2020) National Science Foundation ...

    STTRPhase INational Science Foundation
  3. PT4: Therapeutic Molecules

    Release Date: 02-12-2021Open Date: 02-12-2021 Due Dates: Multiple Close Date: 01-06-2022

    PT4 NSF SBIR Phase I (2021) National Science Foundation ...

    SBIRPhase INational Science Foundation
  4. PT4: Therapeutic Molecules

    Release Date: 02-12-2021Open Date: 02-12-2021 Due Dates: Multiple Close Date: 01-06-2022

    PT4 NSF STTR Phase I (2021) National Science Foundation ...

    STTRPhase INational Science Foundation
  5. PT5: Therapeutic Molecules

    Release Date: 01-11-2022Open Date: 01-11-2022 Due Dates: Multiple Close Date: 10-26-2022

    PT5 SBIR/STTR Phase I (2022) National Science Foundation ...

    SBIR/STTRPhase INational Science Foundation
  6. PT4: Therapeutic Molecules

    Release Date: 11-22-2022Open Date: 11-22-2022 Due Dates: Multiple Close Date: 03-04-2024

    NA

    SBIR/STTRPhase INational Science Foundation
  7. NIH/NIAID 088: Therapeutic Targeting of Intracellular HIV-1 Proteins or Nucleic Acids

    Release Date: 07-09-2020Open Date: 07-09-2020Due Date: 10-26-2020Close Date: 10-26-2020

    Fast Track Proposals will be accepted. Direct to Phase II will not be accepted. Number of anticipated awards: 2 Budget (total costs): Phase I: $300,000 for up to one year; Phase II: $2,000,000 for up to 3 years. Background During the HIV life-cycle, multiple viral nucleic acids and proteins are expressed inside the infected cell. All are critical to support assembly, release, and maturation of ...

    SBIRPhase I/Phase IIDepartment of Health and Human Services
  8. A11-122: Therapy for Secondary Lymphedema

    Release Date: 07-28-2011Open Date: 08-29-2011Due Date: 09-28-2011Close Date: 09-28-2011

    TECHNOLOGY AREAS: BiomedicalACQUISITION PROGRAM: Office of the Principal Assistant for AcquisitionOBJECTIVE: Develop an innovative, curative treatment for secondary lymphedema that will restore the function of the lymphatic vessel system.

    SBIRPhase IDepartment of DefenseArmy
  9. 24-FT3: The Reduction of Auxiliaries Power Demand on Electric/Battery Operated Transit Buses

    Release Date: 02-08-2024Open Date: 02-08-2024Due Date: 03-07-2024Close Date: 03-07-2024

    24-FT3 FY24.1 DOT SBIR Solicitation Department of Transportation ...

    SBIRPhase IDepartment of Transportation
  10. N202-124: Thermal and Magnetic Packaging for Large Superconducting Systems

    Release Date: 05-06-2020Open Date: 06-03-2020Due Date: 07-02-2020Close Date: 07-02-2020

    TECHNOLOGY AREA(S): Electronics, Information Systems, SensorsOBJECTIVE: Invent and experimentally validate one or more schemes for packaging of Multi-Chip Modules (MCM) that simultaneously satisfies the system needs for volume conservation and for the thermal and magnetic field conditions that allow proper operation of complex superconducting MCM. The approach developed must be inherently notional ...

    SBIRPhase I/Phase IIDepartment of DefenseNavy
US Flag An Official Website of the United States Government